GUANGDONG JIAYING PHARMACEUTICAL CO., LTD

Guangdong Jiaying Pharmaceutical Co., Ltd

002198

CNE1000008P1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-07-16 EDT			5-day change	1st Jan Change
6.41 ^CNY	-2.88%		-10.72%	-11.95%

07-10	Yangtianhe Pharmacy Co., Ltd. signed Share Transfer Agreement to acquire 7% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 360 million.	CI
07-08	Huang Junjie completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Liu Libiao.	CI

Guangdong Jiaying Pharmaceutical Co., Ltd signed an equity transfer agreement to acquire 45% stake in Guangdong Huaqingyuan Bio-Technology Co., Ltd. from Ling Fengqing for CNY 6.8 million.

January 01, 2014 at 11:00 pm

Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) signed an equity transfer agreement to acquire 45% stake in Guangdong Huaqingyuan Bio-Technology Co., Ltd. from Ling Fengqing for CNY 6.8 million in cash on December 30, 2013. Guangdong Jiaying Pharmaceutical will pay the consideration within 15 working days from the signing of the agreement. The Board of Directors of Guangdong Jiaying Pharmaceutical approved the transaction.

Latest news about Guangdong Jiaying Pharmaceutical Co., Ltd

Yangtianhe Pharmacy Co., Ltd. signed Share Transfer Agreement to acquire 7% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 360 million.	07-09	CI
Huang Junjie completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Liu Libiao.	07-07	CI
Huang Junjie completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Liu Libiao.	07-07	CI
Huang Junjie signed share transfer agreement to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Liu Libiao for CNY 230 million.	06-18	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	04-26	CI
Announcement of Resolutions of Guangdong Jiaying?s Fifth Extraordinary General Meeting of Shareholders in 2021	11-15	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Guangdong Jiaying Pharmaceutical Co., Ltd. Approves Management Appointments	23-06-19	CI
Resolutions on Supervisor Nomination by Guangdong Jiaying Venture Capital	23-06-16	CI
Guangdong Jiaying Venture Capital Submits Proposals Related to Supervisor Nominations	23-06-05	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Guangzhou Taiping Enterprise Management Partnership (Limited Partnership) signed the Share Transfer Agreement to acquire 5% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 195 million.	23-02-20	CI
Jiaying Pharma Sees Up to 3,420% Surge in 2022 Profit	23-01-18	MT
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-26	CI
Jiaying Pharmaceutical’s Profit Crashes 93% in 2021 Despite Revenue Growth	22-03-14	MT
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-11	CI
Liu Libiao completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing.	21-11-07	CI
Chen Shaobin completed the acquisition of 10% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Yonghong.	21-11-07	CI
Liu Libiao agreed to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Huang Zhiyong and Huang Libing for approximately CNY 210 million.	21-11-01	CI
An unknown buyer agreed to acquire 10% stake in Guangdong Jiaying Pharmaceutical Co., Ltd for approximately CNY 430 million.	21-11-01	CI

Chart Guangdong Jiaying Pharmaceutical Co., Ltd

Duration

Period

Chart Guangdong Jiaying Pharmaceutical Co., Ltd

More charts

Company Profile

GUANGDONG JIAYING PHARMACEUTICAL CO., LTD is a China-based company principally engaged in the research, development, manufacture and sales of Chinese patent medicine. The Companyâs main products include Chinese traditional preparations, powders, tablets, capsules and granules, which are mainly applied in the treatment of throat disease, cold, stomach disease and others, as well as for tonic nourish purpose and others. The Company distributes its products mainly in domestic market. Through its subsidiaries, the Company is also engaged in the operation and leasing of self-owned real estate.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
GUANGDONG JIAYING PHARMACEUTICAL CO., LTD	-11.95%	448M
DONG-E-E-JIAO CO.,LTD.	+7.30%	4.69B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.08%	3.66B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.71%	3.11B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.32%	2.65B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.35%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.19%	1.78B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.49%	1.37B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.07%	1.39B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.38B

Alternative Medicine